Russell Investments Group Ltd. Invests $1.51 Million in Alignment Healthcare, Inc. $ALHC

Key Points

• Russell Investments Group Ltd. has acquired 81,493 shares of Alignment Healthcare, Inc. worth approximately $1.5 million, signaling institutional interest in the company.
• Insider transactions revealed CEO John E. Kao sold 180,000 shares for $2.41 million, reflecting a 10.39% decrease in his ownership position.
• Analysts have recently upgraded Alignment Healthcare's stock ratings, with the consensus rating turning to "Moderate Buy" and an average target price set at $18.83.

Russell Investments Group Ltd. bought a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 81,493 shares of the company's stock, valued at approximately $1,511,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Teacher Retirement System of Texas raised its position in shares of Alignment Healthcare by 109.1% during the 1st quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company's stock valued at $883,000 after buying an additional 24,755 shares during the period. Northern Trust Corp increased its stake in Alignment Healthcare by 8.6% during the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after buying an additional 72,063 shares during the period. New York State Common Retirement Fund increased its stake in Alignment Healthcare by 100.9% during the 1st quarter. New York State Common Retirement Fund now owns 165,642 shares of the company's stock worth $3,084,000 after buying an additional 83,187 shares during the period. Victory Capital Management Inc. lifted its stake in Alignment Healthcare by 905.7% in the first quarter. Victory Capital Management Inc. now owns 114,397 shares of the company's stock worth $2,130,000 after acquiring an additional 103,022 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in Alignment Healthcare by 3,216.9% in the first quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock worth $443,000 after acquiring an additional 23,097 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Stock Up 2.7%

Shares of ALHC traded up $0.45 during trading on Tuesday, reaching $16.81. The company's stock had a trading volume of 225,424 shares, compared to its average volume of 2,984,039. The company has a fifty day moving average of $13.98 and a two-hundred day moving average of $15.37. Alignment Healthcare, Inc. has a twelve month low of $8.65 and a twelve month high of $21.06. The company has a market cap of $3.33 billion, a price-to-earnings ratio of -59.87 and a beta of 1.17. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.14. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business's revenue was up 49.0% on a year-over-year basis. During the same quarter last year, the firm earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have commented on ALHC. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a report on Monday, August 25th. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Insider Buying and Selling at Alignment Healthcare

In other news, Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $16.00, for a total transaction of $400,000.00. Following the sale, the director directly owned 1,152,049 shares in the company, valued at approximately $18,432,784. This represents a 2.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hyong Kim sold 24,800 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $16.00, for a total value of $396,800.00. Following the sale, the insider owned 447,367 shares in the company, valued at $7,157,872. The trade was a 5.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 636,185 shares of company stock worth $9,235,468. Corporate insiders own 6.60% of the company's stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.